Stay updated on Risdiplam in SMA Infants Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Infants Clinical Trial page.

Latest updates to the Risdiplam in SMA Infants Clinical Trial page
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, indicating access is blocked; the rendered page includes the site's header and footer with the 403 message.SummaryDifference19%

- Check25 days agoChange DetectedThe page now shows revision v3.7.0, replacing the previous v3.6.6. This indicates a version update to the page rendering system.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study record now includes two additional NIH grant/contract identifiers (2018 and 2023) in the Other Study ID Numbers. The Revision tag has been updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check67 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a new version of the page is in effect. This appears to be a minor maintenance update rather than a substantive change to the page content.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4. This reflects a minor metadata update to the page rather than a change to substantive content.SummaryDifference0.0%

- Check95 days agoChange DetectedNew update dates (2026-07-09, 2026-07-08, 2026-07) were added to the page, signaling recent maintenance of the study record. These changes do not alter the trial details or eligibility information, but reflect updated record-keeping.SummaryDifference0.2%

Stay in the know with updates to Risdiplam in SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Infants Clinical Trial page.